2016's Top IPOs
- AveXis (AVXS) 92.35%
- Proteostasis Therapeutics, Inc. (PTI) 90.88%
- Reata Pharmaceuticals, Inc. (RETA) 83.09%
- Twilio, Inc. (TWLO) 75.33%
- Editas Medicine (EDIT) 62.94%
- Acacia Communications (ACIA) 62.00%
- SiteOne Landscape Supply, Inc. (SITE) 60.29%
- Intellia Therapeutics (NTLA) 45.39%
- BATS Global Markets, Inc. (BATS) 35.74%
- American Renal Associates Holdings (ARA) 27.77%
On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.
J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.
Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.
- Izea Inc. Common (IZEA) Files $75M Common Stock Shelf
- Universal Technical Institute (UTI) Raises $70M in Private Placement of Convertible Preferred Stock
- Cyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement
- Eiger BioPharmaceuticals (EIGR) Enters $25M Stock Sales Agreement
- Cascadian Therapeutics (CASC) Prices 35M Shares at $0.80/Share, Concurrent Series D Convertible Preferred Stock Offering
- See More
|6/10/2016||Atkore International||ATKR||12 Mil||$16.00||$16.07||0.44%||Credit Suisse, Deutsche BankSecurities and J.P. Morgan|
|6/2/2016||Clearside Biomedical||CLSD||7.2 Mil||$7.00||$6.80||-2.86%||Cowen and Company and Stifel|
|6/10/2016||China Online Education Group||COE||2.4 Mil||$19.00||$20.92||10.11%||Morgan Stanley, Credit Suisse|
|5/26/2016||Cotiviti Holdings, Inc.||COTV||12.5 Mil||$19.00||$18.95||-0.26%||Goldman, Sachs & Co., J.P. Morgan, Barclays, Citigroup, Credit Suisse, Morgan Stanley, RBC Capital Markets, SunTrust Robinson Humphrey, Baird, William Blair|
|5/26/2016||GMS Inc.||GMS||7 Mil||$21.00||$21.53||2.52%||Barclays Capital Inc. and Credit Suisse Securities|
|6/2/2016||Moleculin Biotech||MBRX||1.54 Mil||$6.00||$6.84||14.00%||Bonwick Capital Partners, LLC|
|6/2/2016||NantHealth||NH||6.5 Mil||$14.00||$12.71||-9.21%||Jefferies LLC and Cowen and Company|
|6/22/2016||Selecta Biosciences||SELB||5 Mil||$14.00||$14.00||0.00%||UBS Investment Bank and Stifel|
|6/23/2016||Twilio, Inc.||TWLO||10 Mil||$15.00||$26.30||75.33%||Goldman, Sachs & Co., J.P. Morgan, Allen & Company LLC, Pacific Crest Securities, JMP Securities, William Blair, Canaccord Genuity|
|5/26/2016||US Foods Holding||USFD||44.444 Mil||$23.00||$23.34||1.48%||Goldman, Sachs & Co., Morgan Stanley and J.P. Morgan|
|N/A||Sidoti & Company, Inc.||SDTI||N/A||N/A||WR Hambrecht + Co., Sidoti & Company|
|N/A||Poseidon Containers Holdings Corp.||PCON||N/A||$14-$16||Morgan Stanley, UBS Investment Bank|
|N/A||BioCardia, Inc.||BCDA||3.9 Mil||$12-$14||Cantor Fitzgerald & Co., Roth Capital Partners, Maxim Group LLC|
|N/A||Digicel Group Limited||DCEL||124.1 Mil||$13-$16||J.P. Morgan, UBS Investment Bank, Citigroup, Barclays, Credit Suisse|
|N/A||GenSight Biologics S.A.||GNST||4.7 Mil||$13-$15||Leerink Partners, Evercore ISI, Canaccord Genuity|
|N/A||GenSight Biologics S.A.||GBIT||N/A||N/A||Morgan Stanley, Goldman, Sachs & Co., Cowen and Company, Wedbush PacGrow|
|N/A||UTAC Holdings Ltd.||UTAC||N/A||N/A||BofA Merrill Lynch, Citigroup, Credit Suisse|
|N/A||VIZIO, Inc.||VZIO||N/A||N/A||BofA Merrill Lynch, Deutsche Bank Securities, Citigroup, BMO Capital Markets, Piper Jaffray, Wells Fargo Securities, Roth Capital Partners|
|N/A||NEP Group||NEPG||13 Mil||$15-$17||Barclays, Morgan Stanley, Jefferies, Macquarie Capital, RBC Capital Markets|
|N/A||Boxlight||BOXL||1.818 Mil||$10-$12||Aegis Capital Corp|
Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.
The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.
Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.